Dan Weidner is a market research professional specializing in neurology, competitive intelligence, and insights within the Pharmaceutical, Biotech, Medical Device, and consumer products industries. They have worked in various roles, including as Global Insights Lead at argenx since 2025 and as Associate Director at Bristol Myers Squibb from 2020 to 2022. Dan’s expertise encompasses clinical trial design, forecasting, pricing strategy, and market research, and they have previously held positions with notable firms such as Ipsos and RG+A. Dan earned a BS in Biology from Dickinson College and an MBA from the University of Maryland's Robert H. Smith School of Business.
This person is not in the org chart
This person is not in any teams
This person is not in any offices